KBI Biopharma Inc., a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), has appointed Peter Carbone as its new Chief Quality Officer.
 
“We have made a commitment to establishing KBI Biopharma as a thought leader and catalyst for change in Regulatory Affairs within the biopharma sector,” said J.D. Mowery, President & CEO of KBI Biopharma. “Peter’s addition to our team bolsters our expertise in quality and regulatory compliance and facilitates our continued transformation in support of our current and future customers. His passion for making a difference in the world, coupled with his drive to develop and deliver innovative products that improve patients’ lives, makes him an invaluable asset to KBI.”

About Peter Carbone

Carbone brings over 35 years of experience in operations, quality, and technology leadership in a diverse range of areas in the life sciences spectrum, including biotechnology, pharmaceuticals, and advanced therapies. He will lead KBI’s Quality and Regulatory Affairs team, spearheading compliance and regulatory initiatives for customers worldwide and positioning KBI to provide the services, expertise, and leadership to partner with health authorities on regulatory policy.
 
“I am thrilled to join KBI Biopharma during a time of significant evolution for the company,” said Carbone. “We are poised for remarkable advancements in the biopharma industry, and I look forward to working with this talented team to drive innovation, ensure quality, deliver exceptional results, and ultimately make a meaningful impact on patients’ lives worldwide.”
 
Prior to joining KBI, Carbone led engineering, operations, and quality organizations at major pharmaceutical companies, including Bayer, Amgen, Allergan, Novartis, Acorda, and the Center of Breakthrough Medicines.
 
He holds a BS in Chemical Engineering from Rensselaer Polytechnic Institute.
 
This news comes months after KBI appointed Tony Fraij, chief operating officer; Shaguna Seth, chief of staff and global PMO leader; Katie Edgar, senior vice president of corporate strategy and alliance management; and Sarah Wakefield, senior vice president, corporate communications.